Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.
By A. Algra, Peter M. Rothwell. The Lancet Oncology, 2012
803 citations recorded by the source corpus.
Subfields: Cancer Research, Pharmacology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/70761d40e06ea42acab8946091a1b6a51fba9abd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. M. Mota
- R. Barroso-Sousa
- M. A. Hadi
- A. Mohiuddin
- A. Jairoun
- A. John
- L. Ming
- B. Carneiro
Citations in the corpus
- Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies (2022, background): “Equally, it has been established that the risk of CRC can be reduced by physical activity [75], regular aspirin consumption [76,77], and hormone replacement therapy [78], while certain studies have also found that consumption of milk and whole grains may help protect against CRC [74].”
- Wnt/beta-catenin pathway: modulating anticancer immune response (2017, background): “Through inhibiting cyclooxygenase-2 (COX-2), aspirin decreases the availability of prostaglandin E2 (PGE2), therefore reducing WNT levels [78].”